Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer.
LEESBURG, Fla., July 8, 2026 /PRNewswire/ — RunStar®, the brand behind innovative at-home health devices designed to simplify personalized health tracking, is expanding its line with the launch of its newest device. The RunStar Smart Blood Pressure Monitor (BP-206) builds on RunStar’s growing portfolio of health monitoring technology, offering users an intuitive way to measure, track, and better understand their blood pressure from home.
The new aerated material could enable longer-lasting bandages, implants, and wearable sensors.
Neuspera Medical announced today that the Centers for Medicare & Medicaid Services (CMS) confirmed its SNM system’s billing code.
Carea, the pregnancy and postnatal wellbeing app, has launched its new Contraction Timer designed to support women during labour through a combination of contraction tracking, labour pattern analysis and wellbeing tools.
Jenscare Scientific announced today that it received CE mark approval for its LuX-Valve plus under EU Medical Device Regulation (MDR).
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF platform (DE STSF).
Each year, thousands of patients in the United States wait for a liver transplant, while transplant teams must make rapid, difficult decisions about whether donor organs are suitable for use.
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis.